A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
for B-Cell Non-Hodgkin Lymphoma
Drug: Cemiplimab
2 locations incl. Scottsdale
Sponsor: Mayo Clinic
Sex: All·Age: 18+
Code: NCT03017820·Phase 1·Recruiting